ARCHIVES

Biotheraputics Inc. Markets ‘Custom Made’ Experimental Therapy

This article is from The Cancer Letter archive.

Vol. 11 No. 32 | August 9, 1985

Download PDF Visit The Full Archive

Related Articles

FDA Tightens Conflict of Interest Rules For Advisors.

March 23, 2007

Knowing Tumor Cell Structure Improves Treatment Decisions

March 27, 2009

NIH, FDA to tighten, review consulting rules as Congressional inquiry continues.

May 21, 2004

NCAB Approves New Pancreatic Cancer Project, Hears Favorable Reports On Organ site Programs

November 29, 1974

FDA Delays Decision On Avastin Approval For Breast Cancer

September 24, 2010

NCI Provides $40 Million To Four Centers For Cancer Communications Research.

June 27, 2003